FDA approves new epinephrine injector from Adamis Pharmaceuticals
The U.S. Food & Drug Administration (FDA) has finally approved a new epinephrine injector for anaphylaxis, increasing competition for the controversially expensive injector EpiPen.
Symjepi, the new epinephrine injector made by Adamis Pharmaceuticals Corp., is a syringe prefilled with the epinephrine hormone, which is capable of stopping life-threatening allergic reactions from insect stings, foods like eggs and certain medications.
Accordiing to San Diego-based Adamis, its new product is easier to use than EpiPen that comes filled with a set dose and is accompanied by a training device.
In addition, Symjepi will be easier to carry as it is notably smaller than EpiPen. Most kids and adults with severe allergies have to carry an injector wherever they go.
Evercore ISI analyst Umer Raffat and some others have pointed out that Symjepi isn’t totally identical to EpiPen; so its price will definitely be a key consideration.
Currently, Mylan Pharmaceuticals’ EpiPen costs in the range of $630 to $700 without insurance. The new generic version retails for around $225 to $425.
European Commission President Jean-Claude Juncker’s proposal to expand Eurozone by bringing more countries into it has triggered controversy, mainly in Germany, where Chancellor Angela Merkel is seeking re-election.
Wall Street soared to record highs on Friday, thanks to robust trading in telecommunication shares as well as bouncing back of technology shares after a couple of days of declines.
The European Union’s effort to increase tax on turnover of technology multinationals like Google and Amazon gained momentum as nearly one third of EU states are now in support of the plan, French Finance Minister Bruno Le Maire said on Friday.
Stock price of electric vehicle maker Tesla gained more than 3 per cent on Thursday, after the company’s founder and CEO Elon Musk confirmed plans to introduce an electric semi-truck.
Bitcoin suffered its steepest decline since January 2015 on Friday after a senior executive of China’s state-backed internet finance body said the controversial digital currency could pose risks because Bitcoins and other cryptocurrencies could be
Cupertino, California-based Apple Incorporated has quietly increased prices for the 256GB and 512GB models of its iPad Pro by $50, MacRumors reported.